NCT06692725View on ClinicalTrials.gov

De-escalation of Neoadjuvant Chemotherapy Regimens With Immunotherapy Among TNBC

RecruitingOBSERVATIONAL

Enrollment

380

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions

Triple Negative Breast Cancer

Trial Locations (1)

100044

RECRUITING

Peking University People's Hospital, Beijing

All Listed Sponsors

lead

Peking University People's Hospital

OTHER